Medicine passport

Rinvoq 15 mg

The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.

Active substance
Upadacitinib
Strength
15 mg
Form
Tablet, Extended Release
ATC code
Not stated by the register
Registered in
United States · AbbVie Inc.
Prescription
Prescription only
NDC
0074-2306

Source: NDC Directory · 2026-09-13

Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.

Listed in other countries

Spain 1 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
RINVOQ15 mg · comprimido de liberación prolongadaPrescription onlyAbbvie Deutschland Gmbh & Co. Kg1191404001

Source: CIMA — Centro de Información online de Medicamentos (Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)) · 2026-09-30 · Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA.

Canada 1 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
RINVOQ15 mg · tablet (extended-release)Prescription onlyAbbvie Corporation02495155

Source: Drug Product Database (Health Canada) · 2026-09-30 · Contains information licensed under the Open Government Licence – Canada.

Same active substance, but no match for this strength and form

Countries covered: United States, Bulgaria, European Union, Spain, France, Netherlands, Canada, Switzerland. A country missing from the list may still sell this medicine: Mediclarum reads only these registers.

Register data as of 2026-09-13. Mediclarum stores nothing about you for this page. https://www.mediclarum.com/us/en/medicines/rinvoq-15-mg-tablet-extended-release